• 1. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Isopropyl 2-amino-5-bromobenzoate (CAS No. 934110-16-4): A Comprehensive Overview

Isopropyl 2-amino-5-bromobenzoate, identified by its Chemical Abstracts Service (CAS) number 934110-16-4, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and bioorganic synthesis. This compound, characterized by its amine and bromine substituents on a benzoate backbone, exhibits unique chemical properties that make it a valuable intermediate in the development of novel therapeutic agents.

The structural motif of Isopropyl 2-amino-5-bromobenzoate consists of a benzoic acid core modified with an isopropyl ester group at the carboxyl position, a primary amine group at the 2-position, and a bromine atom at the 5-position. This specific arrangement of functional groups imparts distinct reactivity patterns, making it a versatile building block for synthetic chemists. The presence of both an amine and a bromine moiety allows for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings, which are pivotal in constructing complex molecular architectures.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting various biological pathways. Among these pathways, those involving kinases and transcription factors have been extensively studied due to their critical roles in cancer and inflammatory diseases. The< strong> Isopropyl 2-amino-5-bromobenzoate scaffold has emerged as a promising candidate for designing kinase inhibitors due to its ability to engage with hydrogen bonding networks and hydrophobic pockets within the enzyme active sites.

One of the most compelling applications of Isopropyl 2-amino-5-bromobenzoate is in the synthesis of kinase inhibitors. For instance, researchers have leveraged its brominated aromatic ring to develop novel inhibitors of Janus kinases (JAKs), which are implicated in autoimmune disorders such as rheumatoid arthritis and psoriasis. By employing palladium-catalyzed cross-coupling reactions, derivatives of this compound have been linked to heterocyclic scaffolds known to modulate JAK activity. Preliminary in vitro studies have demonstrated potent inhibition of JAK3, a key enzyme in the JAK/STAT signaling pathway, with IC50 values ranging from nanomolar to sub-nanomolar concentrations.

The amine group in Isopropyl 2-amino-5-bromobenzoate also serves as a versatile handle for further derivatization. Researchers have utilized this group to introduce polyethylene glycol (PEG) chains, enhancing the solubility and pharmacokinetic properties of potential drug candidates. PEGylation has become a cornerstone technique in drug development, particularly for improving bioavailability and reducing immunogenicity. By incorporating PEG moieties into kinase inhibitors derived from this scaffold, scientists aim to develop more effective and less toxic therapeutic agents.

In addition to its role in kinase inhibition, Isopropyl 2-amino-5-bromobenzoate has found utility in the development of antimicrobial agents. The bromine substituent at the 5-position can be exploited to generate novel quinolone analogs, which are known for their broad-spectrum antimicrobial activity. Quinolones exert their bactericidal effects by inhibiting DNA gyrase and topoisomerase IV, essential enzymes for bacterial DNA replication and transcription. By modifying the benzoate core with< strong> Isopropyl 2-amino-5-bromobenzoate, researchers have generated derivatives that exhibit enhanced efficacy against multidrug-resistant bacterial strains.

The synthesis of< strong> Isopropyl 2-amino-5-bromobenzoate itself presents an interesting challenge due to the need for precise functional group manipulation. Traditional synthetic routes involve multi-step sequences starting from commercially available benzoic acid derivatives. Key steps include bromination at the desired position using brominating agents such as N-bromosuccinimide (NBS), followed by nucleophilic substitution with isopropyl chloroformate to introduce the ester group. The amine functionality is typically introduced via reductive amination or direct conversion of an existing hydroxyl group under basic conditions.

The purity and yield of< strong> Isopropyl 2-amino-5-bromobenzoate are critical factors influencing its downstream applications. Analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy, high-performance liquid chromatography (HPLC), and mass spectrometry (MS) are employed to confirm structural integrity and quantify impurities. Advances in synthetic methodologies have enabled higher yields and purities, making large-scale production feasible for pharmaceutical applications.

The growing interest in< strong> Isopropyl 2-amino-5-bromobenzoate underscores its significance as a pharmacophore in medicinal chemistry. As our understanding of biological targets advances, so does the demand for innovative intermediates like this one. Future research directions may explore its potential in modulating other therapeutic targets, such as protease enzymes involved in viral replication or transcription factors regulating gene expression.

In conclusion,< strong> Isopropyl 2-amino-5-bromobenzoate (CAS No. 934110-16-4) is a multifaceted compound with broad applications in pharmaceutical research and drug development. Its unique structural features make it an invaluable intermediate for synthesizing kinase inhibitors, antimicrobial agents, and other therapeutic compounds. As synthetic chemistry continues to evolve,< strong> Isopropyl 2-amino-5-bromobenzoate will undoubtedly remain at the forefront of innovation in medicinal chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)